RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 498 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Follow-Up Questions
Who is the CEO of Rxsight Inc?
Dr. Ron Kurtz is the President of Rxsight Inc, joining the firm since 2016.
What is the price performance of RXST stock?
The current price of RXST is $8.32, it has increased 0.97% in the last trading day.
What are the primary business themes or industries for Rxsight Inc?
Rxsight Inc belongs to Health Care industry and the sector is Health Care
What is Rxsight Inc market cap?
Rxsight Inc's current market cap is $340.4M
Is Rxsight Inc a buy, sell, or hold?
According to wall street analysts, 11 analysts have made analyst ratings for Rxsight Inc, including 0 strong buy, 1 buy, 10 hold, 3 sell, and 0 strong sell
